Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 21.10
+0.20 (0.96%)
Jun 12, 2026, 4:50 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 2.01 billion as of June 12, 2026. Its market cap has decreased by -39.66% in one year.
Market Cap
2.01B
Enterprise Value
1.42B
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.10
Market Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 2.01B, a decrease of -51.13%. That is a compound annual growth rate of -30.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 2.01B | -30.82% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.21B |
| Vicore Pharma Holding AB | 2.85B |
| Egetis Therapeutics AB | 2.43B |
| Saniona AB | 1.75B |
| BioInvent International AB | 1.74B |
| Genovis AB (publ.) | 1.32B |
| Medivir AB | 918.97M |
| Infant Bacterial Therapeutics AB | 813.67M |